Alpha Cure Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
Alpha Cure Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Alpha Cure Therapeutics
Robert Zamenhof
Co-Founder and Scientific Advisor of Alpha Cure Therapeutics
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Alpha Cure Therapeutics Email Formats
Alpha Cure Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@alphacuretx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@alphacuretx.com | 100% |
About Alpha Cure Therapeutics
Alpha Cure Therapeutics is developing precision safe (non-radioactive) radioligand therapy via small molecule next-generation BNCT. We aim to cure Breast Cancer including Triple Negative Breast Cancer (+other indications)
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Funding Data
Alpha Cure Therapeutics has never raised funding before.
Peru
Australia
United KingdomFrequently asked questions
Alpha Cure Therapeutics is located in XX.
Alpha Cure Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Alpha Cure Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Alpha Cure Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
